Jon Cuthbert

BeatSwap has launched a new vault-to-earn pre-funding model that allows users to support IP real-world assets onchain in exchange for upfront incentives.

Mesoblast (ASX:MSB) has repaid its senior secured loan from Oaktree Capital Management and partially settled its subordinated royalty facility with NovaQuest Capital Management.

Autosports Group (ASX:ASG) has finalised the acquisition of ten Barry Bourke Motors dealerships in Victoria.

Bybit EU marked Bybit’s seventh anniversary with a Europe-only promotion that reflects how regulated crypto platforms are adapting to MiCAR requirements.

Azenta (NASDAQ:AZTA) has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for $63 million, as the company moves to streamline operations and focus on its core capabilities.

Unicycive Therapeutics (NASDAQ:UNCY) said it has resubmitted its 505(b)(2) New Drug Application to the U.S. Food and Drug Administration for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients receiving dialysis.

DHT Holdings (NYSE:DHT) said it has entered into sale agreements for two very large crude carriers, DHT China and DHT Europe, for a combined consideration of $101.6 million, as the tanker owner continues to optimize its fleet and strengthen liquidity.

iHuman (NYSE: IH), a leading provider of tech-powered intellectual development products in China, announced third-quarter financial results on Monday that reflected the persistent headwinds facing the country's early childhood education sector. The company saw a broad contraction across its key financial metrics and user engagement levels compared to the previous year.

HUTCHMED (NASDAQ:HCM) announced Monday that the China National Medical Products Administration (NMPA) has accepted its New Drug Application for fanregratinib and granted it priority review status.

Ethereum’s staking demand has surged as the validator entry queue overtakes exits, signalling renewed confidence and tightening liquid supply ahead of 2026.